The Hindu : Business : Shasun Chemicals consolidated revenue up; announces 45 p.c. final

Online edition of India's National Newspaper
Thursday, May 31, 2007
ePaper

Business

Business

Shasun Chemicals consolidated revenue up; announces 45 p.c. final

Corporate Reporter

CHENNAI: Shasun Chemicals and Drugs has posted a consolidated revenue of Rs. 793.34 crore and a net profit of Rs. 52.62 crore in the year ended March 31, 2007. The revenue was Rs. 376.90 crore and the net profit Rs. 36.74 crore in the previous year. The consolidated results for the year ended March 31, 2007, also include the results of the U.K. based Rhodia Pharma which was acquired in April 2006. The company has recommended a final dividend of 45 per cent (90 paise per share of the face value of Rs. 2). This, together with the interim of 40 per cent, takes the total dividend to 85 per cent.

Addressing presspersons here on Tuesday, N. Govindarajan, CEO and Managing Director of the company, said the company had turned around the operations of the U.K. based Rhodia Pharma, which was acquired by Shasun Chemicals through its wholly owned subsidiary Shasun Pharma Solutions Ltd. (SPSL).

According to S. Vimal Kumar, Director, SPSL has 19 commercial products under its belt and 17 molecules under phase II and Phase III for launch by its partners. The acquisition has given Shasun Chemicals a global presence in active pharmaceutical ingredients (APIs), custom synthesis and contract manufacturing, Mr. Vimal Kumar said.

Printer friendly page
Send this article to Friends by E-Mail

Business

News Update

Stories in this Section